UPDATE : Friday, May 29, 2020
TissueGene promotes cell gene therapy Invossa ahead of IPO
TissueGene, the U.S.-based biopharmaceutical firm held mostly by Korea’s Ko...
by Lee Hye-seon  |  2017-10-17 14:32
Gemvax&Kael present clinical results of prostatic hyperplasia treatment
Gemvax&Kael released its phase-2 domestic clinical trial results of GV1001,...
by Lee Han-soo  |  2017-10-16 16:09
Stem cell treatment for diabetes nears
Korean diabetes patients might have come one step closer to getting a stem ...
by Nam Doo-hyun  |  2017-10-13 15:47
Samsung BioLogics’ 2nd factory gets FDA approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo  |  2017-10-12 15:31
Celltrion rises high in Korean stock market
South Korean biopharmaceutical firm Celltrion’s shares rose high in the loc...
by Nam Doo-hyun  |  2017-10-11 16:11
Samsung Bioepis teams up with Yuhan for biosimilars
Samsung Bioepis, which recently terminated its biosimilar sales deal with t...
by Lee Hye-seon  |  2017-10-11 14:25
Patents on cancer biomarker kit increase at fast pace
Patents related to cancer biomarker kit, also known as an in-vitro diagnost...
by Lee Han-soo  |  2017-10-10 17:44
CJ Healthcare, YL Biologics signs technology transfer agreement
CJ Healthcare said Thursday that it has signed an agreement with YL Biologi...
by Lee Han-soo  |  2017-09-28 15:01
LegoChem, Geom Therapeutics signs technology transfer accord
LegoChem Bioscience said Wednesday that it has signed an agreement with Geo...
by Lee Han-soo  |  2017-09-27 17:52
Aprogen’s rheumatoid arthritis biosimilar wins sales approval in Japan
Aprogen Pharmaceuticals said Wednesday that the company’s NI-071 (Original:...
by Lee Han-soo  |  2017-09-27 17:45
Celltrion will use Oracle Health platform to streamline processes
Celltrion will use Oracle Health platforms to help streamline regulatory re...
by Marian Chu  |  2017-09-27 10:47
Can Celltrion, Samsung make stable earnings with biosimilar?
Amid the intensifying competition to lower drug prices, market watchers pre...
by Nam Doo-hyun  |  2017-09-26 17:31
Medifron aims high through R&D
Medifron said Friday that it would increase its capital by issuing new stoc...
by Lee Han-soo  |  2017-09-25 16:19
Korea lags far behind in biomedical R&D: report
Korea’s investment in the biomedical research and development lags far behi...
by Nam Doo-hyun  |  2017-09-21 16:14
Biosimilar prescriptions fall by the wayside in Korea
Biosimilar uptake in the Korean market has been dismal, according to data a...
by Marian Chu  |  2017-09-21 14:56
Samsung Bioepis gets additional approval for its biosimilar
Amid the controversy caused by MSD Korea’s alleged decision to cease promot...
by Lee Hye-seon  |  2017-09-21 12:03
MSD dissolves promotion team for Samsung Bioepis’ biosimilars
MSD Korea has dissolved its Samsung Bioepis’s biosimilar promotion team and...
by Lee Han-soo  |  2017-09-21 11:58
Sillajen emerges as biggest beneficiary of preferential listing
Sillajen has emerged as the most successful case of the preferential listin...
by Nam Doo-hyun  |  2017-09-20 17:22
Samsung Bioepis gets nods for phase 3 trials to treat macular degeneration
Samsung Bioepis said Tuesday that it has received Ministry of Food and Drug...
by Lee Han-soo  |  2017-09-19 17:39
Korean biopharmaceutical industry ranked 2nd among emerging countries
The Korean biopharmaceutical industry ranked second only to Singapore regar...
by Marian Chu  |  2017-09-19 10:37
Back to Top